Citation Impact
Citing Papers
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
2011
Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis
2014 StandoutNobel
High burden and pervasive positive selection of somatic mutations in normal human skin
2015 StandoutScience
Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion
2010 StandoutNobel
Identification of human flap endonuclease 1 (FEN1) inhibitors using a machine learning based consensus virtual screening
2017
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
2012 Standout
Immunological aspects of cancer chemotherapy
2007
Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review
2014
The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC
2016
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells
2014
Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels
2013
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
2007 StandoutNature
Global Cancer Statistics, 2002
2005 Standout
Poly(ADP-ribosyl)ation in mammalian ageing
2007
The biology and management of non-small cell lung cancer
2018 StandoutNature
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
2010 Standout
Cancer despite immunosurveillance: immunoselection and immunosubversion
2006
A microRNA component of the p53 tumour suppressor network
2007 StandoutNature
Cushing's syndrome
2015 Standout
Lung Cancer
2008 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
2022 Standout
Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes
2007
VHL and p53: Tumor Suppressors Team Up to Prevent Cancer
2006 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking
2022
The Human Transcription Factors
2018 Standout
miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir
2015
HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation
2005
Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
2010 StandoutNobel
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Genetic variants in pre-eclampsia: a meta-analysis
2013
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
DNA Damage, Aging, and Cancer
2009 Standout
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
An efficient and sensitive method for preparing cDNA libraries from scarce biological samples
2014 StandoutNobel
The P53 pathway: what questions remain to be explored?
2006
Oesophageal carcinoma
2013 Standout
Immunity, Inflammation, and Cancer
2010 Standout
The Genetics of Transcription Factor DNA Binding Variation
2016
Aurora Kinases and Their Inhibitors: More Than One Target and One Drug
2007
limma powers differential expression analyses for RNA-sequencing and microarray studies
2015 Standout
Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer
2017 StandoutNobel
DNA repair dysregulation from cancer driver to therapeutic target
2012
Communication by Extracellular Vesicles: Where We Are and Where We Need to Go
2016 Standout
Divergent Cardiopulmonary Actions of Heme Oxygenase Enzymatic Products in Chronic Hypoxia
2009
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression
2006
Ultralow‐Fouling, Functionalizable, and Hydrolyzable Zwitterionic Materials and Their Derivatives for Biological Applications
2009 Standout
Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers
2014
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
The genetics of the p53 pathway, apoptosis and cancer therapy
2008
Calreticulin exposure dictates the immunogenicity of cancer cell death
2006 Standout
Mesoscopic architectures of porous coordination polymers fabricated by pseudomorphic replication
2012 StandoutNobel
Whole-genome molecular haplotyping of single cells
2010
Pre-eclampsia
2015 Standout
The cancer genome
2009 StandoutNature
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma
2002
Antioxidant Gene Polymorphisms and Susceptibility to a Rapid Decline in Lung Function in Smokers
2002
Digoxin inhibits development of hypoxic pulmonary hypertension in mice
2012 StandoutNobel
Outdoor air pollution and cancer: An overview of the current evidence and public health recommendations
2020
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Esophageal cancer: epidemiology, pathogenesis and prevention
2008
Heme Oxygenases in Cardiovascular Health and Disease
2016
Separation technologies for the recovery and dehydration of alcohols from fermentation broths
2008
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
A Single Nucleotide Polymorphism in the MDM2 Gene Disrupts the Oscillation of p53 and MDM2 Levels in Cells
2007
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote
2013 Standout
Film Thickness Dependence of Protein Adsorption from Blood Serum and Plasma onto Poly(sulfobetaine)-Grafted Surfaces
2008
The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads
2019 Standout
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Phosphodiesterase 11A (PDE11A) and Genetic Predisposition to Adrenocortical Tumors
2008
Metal–Organic Frameworks in Biomedicine
2011 Standout
MLL4 mediates differentiation and tumor suppression through ferroptosis
2021
DNA Repair Pathways in Clinical Practice: Lessons From Pediatric Cancer Susceptibility Syndromes
2006
PubChem in 2021: new data content and improved web interfaces
2020 Standout
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
2013 Standout
Works of Wen Tan being referenced
Characterization of Functional Excision Repair Cross-Complementation Group 1 Variants and Their Association with Lung Cancer Risk and Prognosis
2008
Genetic Variants on Chromosome 15q25 Associated with Lung Cancer Risk in Chinese Populations
2009
Functional Genetic Variations in Cytotoxic T-Lymphocyte Antigen 4 and Susceptibility to Multiple Types of Cancer
2008
Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction
2004
FunctionalFEN1polymorphisms are associated with DNA damage levels and lung cancer risk
2009
Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility
2005
Genetic polymorphisms in cell cycle regulatory genesMDM2 andTP53 are associated with susceptibility to lung cancer
2005
A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers
2007
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
2010
Combined Effect of Genetic Polymorphisms in P53, P73, and MDM2 on Non-small Cell Lung Cancer Survival
2011
Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib
2009
Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms
2007
FASL –844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer
2005
Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China.
2000
Haplotypes in Matrix Metalloproteinase Gene Cluster on Chromosome 11q22 Contribute to the Risk of Lung Cancer Development and Progression
2006
Pervaporation study of aqueous ethanol solution through zeolite-incorporated multilayer poly(vinyl alcohol) membranes: Effect of zeolites
2005
Polymorphisms in DNA Base Excision Repair Genes ADPRT and XRCC1 and Risk of Lung Cancer
2005
Correlation between a single nucleotide polymorphism in the matrix metalloproteinase-2 promoter and risk of lung cancer.
2002
Functional STK15 Phe31Ile Polymorphism Is Associated with the Occurrence and Advanced Disease Status of Esophageal Squamous Cell Carcinoma
2004
Functional Haplotypes in the Promoter of Matrix Metalloproteinase-2 Predict Risk of the Occurrence and Metastasis of Esophageal Cancer
2004
Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population (Review)
2003
Identification of Functional Genetic Variants in Cyclooxygenase-2 and Their Association With Risk of Esophageal Cancer
2005
A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma.
2003
Exposure to airborne PM2.5 suppresses microRNA expression and deregulates target oncogenes that cause neoplastic transformation in NIH3T3 cells
2015
The Role ofP53andMDM2Polymorphisms in the Risk of Esophageal Squamous Cell Carcinoma
2005